We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
-6.73%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.47B
AUM Growth
-$295M
Cap. Flow
-$1.59B
Cap. Flow %
-35.66%
Top 10 Hldgs %
41.85%
Holding
141
New
13
Increased
10
Reduced
16
Closed
19

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$48.9M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$45.3M
3
LUNG icon
Pulmonx
LUNG
+$34.3M
4
AHCO icon
AdaptHealth
AHCO
+$25.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$23.7M

Top Sells

Rank Stock Value
1
APR
Apria, Inc. Common Stock
APR
+$54M
2
GKOS icon
Glaukos
GKOS
+$41.9M
3
PTGX icon
Protagonist Therapeutics
PTGX
+$40.1M
4
CNC icon
Centene
CNC
+$36.9M
5
PCRX icon
Pacira BioSciences
PCRX
+$35.9M

Sector Composition

Rank Sector Weight
1 Healthcare 54.44%
2 Financials 1.5%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIGS icon
101
FIGS
FIGS
$1.69B
– –
-829,707
Closed -$22.9M
HYPR icon
102
Hyperfine
HYPR
$92.1M
– –
-1,000,000
Closed -$7.25M
PCRX icon
103
Pacira BioSciences
PCRX
$1.05B
– –
-596,338
Closed -$35.9M
PRVA icon
104
Privia Health
PRVA
$3.13B
– –
-300,000
Closed -$7.76M
PTGX icon
105
Protagonist Therapeutics
PTGX
$8.7B
– –
-1,172,943
Closed -$40.1M
PYXS icon
106
Pyxis Oncology
PYXS
$180M
– –
-311,754
Closed -$3.42M
SRPT icon
107
Sarepta Therapeutics
SRPT
$1.6B
– –
-141,000
Closed -$12.7M
WEAV icon
108
Weave Communications
WEAV
$551M
– –
-554,519
Closed -$8.42M
WVE icon
109
Wave Life Sciences
WVE
$1.12B
– –
-552,690
Closed -$1.74M
NVRO
110
DELISTED
NEVRO CORP.
NVRO
– –
-216,000
Closed -$17.5M
LIAN
111
DELISTED
LianBio American Depositary Shares
LIAN
– –
-1,782,747
Closed -$11M
MTACU
112
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$0 ﹤0.01%
+1
New +$10
EUCRU
113
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
$0 ﹤0.01%
+1
New +$10
VIVO
114
DELISTED
Meridian Bioscience Inc
VIVO
– –
-1,125,083
Closed -$23M
SRSAU
115
DELISTED
Sarissa Capital Acquisition Corp. Unit
SRSAU
$0 ﹤0.01%
+1
New +$10
APR
116
DELISTED
Apria, Inc. Common Stock
APR
– –
-1,655,795
Closed -$54M
BDSI
117
DELISTED
BioDelivery Sciences International, Inc.
BDSI
– –
-29,204
Closed -$91K
1 2 3 4
5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2022 Portfolio in Review

As of Q1 2022, Deerfield Management held 141 positions worth $4.47B, down 6.2% from $4.77B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Deerfield Management withdrew a net $1.59B in Q1 2022, closing 19 positions and reducing 16 holdings. Its most notable exit was Apria, Inc. Common Stock, an estimated $54M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, down from 63% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Deerfield Management opened a new position in Gilead Sciences worth $45.5M.

  • Deerfield Management's largest Q1 2022 buy was Gilead Sciences: 765,489 shares worth $45.5M.
  • Deerfield Management added most to Pulmonx in Q1 2022, an estimated $34.3M increase.
  • Deerfield Management's biggest Q1 2022 reduction was Glaukos, cutting an estimated $41.9M.
  • Deerfield Management fully exited Apria, Inc. Common Stock in Q1 2022, selling an estimated $54M.
  • Deerfield Management's ten largest holdings make up 42% of its $4.47B portfolio in Q1 2022.
  • Deerfield Management opened 13 new positions and closed 19 in Q1 2022.
  • Deerfield Management's portfolio value fell 6.2% quarter-over-quarter to $4.47B.

Based on Deerfield Management's 13F filing for Q1 2022, filed 16 May 2022.